Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: Antagonization of Heparin With Protamine Sulfate After TAVI [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether protamine sulfate can antagonize heparin after transcatheter aortic valve implantation, and the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)
  • Protamine sulfate (protamine sulfate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Aortic Valve Stenosis, Heart Valve Diseases | Phase 3 | Status: RECRUITING